trending Market Intelligence /marketintelligence/en/news-insights/trending/bW90VTskgX08eZkkgda5Yw2 content esgSubNav
In This List

Kubota Pharmaceutical to terminate SEC filing obligations

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector

Blog

Insight Weekly: Energy reforms after midterms; Crisis ends 'age of gas'; bank deposits fall


Kubota Pharmaceutical to terminate SEC filing obligations

Kubota Pharmaceutical Holdings Co., Ltd. plans to terminate its reporting obligations with the U.S. Securities and Exchange Commission.

The Tokyo-based clinical stage ophthalmology company plans to file a Form 15F with the SEC and the obligations will be suspended 90 days after that.

The administrative burden and costs associated with being a U.S. reporting company outweigh the benefits, the company said a news release.

Kubota will continue to its filings with Japanese securities regulators and its common shares will continue to trade on the Tokyo Stock Exchange.